TMB cut-offs fail to predict benefit of PD-1 blockade in gastroesophageal adenocarcinoma in KEYNOTE-061

Ann Oncol. 2021 Sep;32(9):1188-1189. doi: 10.1016/j.annonc.2021.06.006. Epub 2021 Jun 15.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma* / drug therapy
  • B7-H1 Antigen / genetics
  • Biomarkers, Tumor
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Lung Neoplasms*
  • Mutation
  • Programmed Cell Death 1 Receptor

Substances

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Programmed Cell Death 1 Receptor